A Study of Radiation Therapy and Cemiplimab for People With Skin Cancer
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Christopher Barker, MD
Memorial Sloan Kettering Cancer Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
13 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Colorado (data Collection Only)
Aurora, Colorado, United States
- Moffitt Cancer Center (data Collection Only)
Tampa, Florida, United States
- Memorial Sloan Kettering Cancer Center at Basking Ridge (all Protocol Activities)
Basking Ridge, New Jersey, United States
- Memorial Sloan Kettering Monmouth (all Protocol Activities)
Middletown, New Jersey, United States
- Memorial Sloan Kettering Bergen (all Protocol Activities)
Montvale, New Jersey, United States
- Memorial Sloan Kettering Suffolk-Commack (all Protocol Activities)
Commack, New York, United States
- Memorial Sloan Kettering Westchester (all Protocol Activities)
Harrison, New York, United States
- Memorial Sloan Kettering Cancer Center (all Protocol Activities)
New York, New York, United States
- Memorial Sloan Kettering Nassau (all Protocol Activities)
Rockville Centre, New York, United States
- Cleveland Clinic (data Collection Only)
Cleveland, Ohio, United States
- Fox Chase Cancer Center (data Collection Only)
Philadelphia, Pennsylvania, United States
- Medical University of South Carolina
Charleston, South Carolina, United States
- University of Washington (data Collection Only)
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 6 Oct 2022
- Primary completion
- 6 Oct 2026
- Completion
- 6 Oct 2026
- Last update posted
- 15 May 2026
- Registered enrollment
- 34
- Registry id
- NCT05574101
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.